EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Outline of Salivary Gland Pathogenesis of Sjögren’s Syndrome and Current Therapeutic Approaches

Yoshiaki Yura, Masakazu Hamada

International Journal of Molecular Sciences · 06.07.2023 · 24 (13) · 11179

DOI: 10.3390/ijms241311179 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.07.2023. Verfasst von Yoshiaki Yura und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral & Maxillofacial Oncology and Surgery, Osaka University Graduate School of Dentistry, Osaka 565-0871, Japan. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Xerostomia. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 260 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sjögren’s syndrome (SS) is an autoimmune disease characterized by the involvement of exocrine glands such as the salivary and lacrimal glands. The minor salivary glands, from which tissue samples may be obtained, are important for the diagnosis, evaluation of therapeutic efficacy, and genetic analyses of SS. In the onset of SS, autoantigens derived from the salivary glands are recognized by antigen-presenting dendritic cells, leading to the activation of T and B cells, cytokine production, autoantibody production by plasma cells, the formation of ectopic germinal centers, and the destruction of salivary gland epithelial cells. A recent therapeutic approach with immune checkpoint inhibitors for malignant tumors enhances the anti-tumor activity of cytotoxic effector T cells, but also induces SS-like autoimmune disease as an adverse event. In the treatment of xerostomia, muscarinic agonists and salivary gland duct cleansing procedure, as well as sialendoscopy, are expected to ameliorate symptoms. Clinical trials on biological therapy to attenuate the hyperresponsiveness of B cells in SS patients with systemic organ involvement have progressed. The efficacy of treatment with mesenchymal stem cells and chimeric antigen receptor T cells for SS has also been investigated. In this review, we will provide an overview of the pathogenesis of salivary gland lesions and recent trends in therapeutic approaches for SS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sjogren's SyndromeXerostomiaHumansSalivary Glands, MinorGerminal CenterSalivary Ducts

Stichwörter der Autor:innen

Sjögren’s syndromebiological therapyimmune checkpoint inhibitormonoclonal antibodymuscarinic agonistpathogenesissalivary glandsialendoscopy

Autor:innen und Institutionen

  • Department of Oral & Maxillofacial Oncology and Surgery, Osaka University Graduate School of Dentistry, Osaka 565-0871, Japan.

Zitieren

APA

Yura, Y., & Hamada, M. (2023). Outline of Salivary Gland Pathogenesis of Sjögren’s Syndrome and Current Therapeutic Approaches. International Journal of Molecular Sciences, 24(13), 11179. https://doi.org/10.3390/ijms241311179

Vancouver

Yura Y, Hamada M. Outline of Salivary Gland Pathogenesis of Sjögren’s Syndrome and Current Therapeutic Approaches. International Journal of Molecular Sciences. 2023;24(13):11179. doi:10.3390/ijms241311179

BibTeX
@article{Yura2023,
  author = {Yura, Yoshiaki and Hamada, Masakazu},
  title = {Outline of Salivary Gland Pathogenesis of Sjögren’s Syndrome and Current Therapeutic Approaches},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {13},
  pages = {11179},
  doi = {10.3390/ijms241311179}
}
Kostenlos starten →